Global Gastrointestinal Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Gastrointestinal market size was valued at USD 35710 million in 2023 and is forecast to a readjusted size of USD 44400 million by 2030 with a CAGR of 3.2% during review period.

Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.

Global Gastrointestinal key players include AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 25%.

Europe is the largest market, with a share about 45%, followed by Asia, and North America, both have a share over 45 percent.

In terms of product, Prescription Gastrointestinal Drug is the largest segment, with a share over 80%. And in terms of application, the largest application is Chronic Gastritis, followed by Peptic Ulcer, etc.

The Global Info Research report includes an overview of the development of the Gastrointestinal industry chain, the market status of Chronic Gastritis (Prescription Gastrointestinal Drug, OTC Gastrointestinal Drug), Functional Dyspepsia (Prescription Gastrointestinal Drug, OTC Gastrointestinal Drug), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gastrointestinal.

Regionally, the report analyzes the Gastrointestinal markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gastrointestinal market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Gastrointestinal market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gastrointestinal industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Prescription Gastrointestinal Drug, OTC Gastrointestinal Drug).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gastrointestinal market.

Regional Analysis: The report involves examining the Gastrointestinal market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gastrointestinal market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Gastrointestinal:
Company Analysis: Report covers individual Gastrointestinal players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gastrointestinal This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Chronic Gastritis, Functional Dyspepsia).

Technology Analysis: Report covers specific technologies relevant to Gastrointestinal. It assesses the current state, advancements, and potential future developments in Gastrointestinal areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gastrointestinal market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Gastrointestinal market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Prescription Gastrointestinal Drug
    OTC Gastrointestinal Drug

Market segment by Application
    Chronic Gastritis
    Functional Dyspepsia
    Peptic Ulcer
    Acute Gastroenteritis
    Others

Market segment by players, this report covers
    AstraZenec
    Sanofi
    Bayer
    Pfizer
    GlaxoSmithKline
    Teva
    Zeria（Tillotts）
    Perrigo
    Boehringer Ingelheim
    Purdue Pharma
    C.B. Fleet
    Abbott
    Jiangzhong
    Xian-Janssen

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gastrointestinal product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gastrointestinal, with revenue, gross margin and global market share of Gastrointestinal from 2019 to 2024.
Chapter 3, the Gastrointestinal competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Gastrointestinal market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gastrointestinal.
Chapter 13, to describe Gastrointestinal research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Gastrointestinal
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Gastrointestinal by Type
        1.3.1 Overview: Global Gastrointestinal Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Gastrointestinal Consumption Value Market Share by Type in 2023
        1.3.3 Prescription Gastrointestinal Drug
        1.3.4 OTC Gastrointestinal Drug
    1.4 Global Gastrointestinal Market by Application
        1.4.1 Overview: Global Gastrointestinal Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Chronic Gastritis
        1.4.3 Functional Dyspepsia
        1.4.4 Peptic Ulcer
        1.4.5 Acute Gastroenteritis
        1.4.6 Others
    1.5 Global Gastrointestinal Market Size & Forecast
    1.6 Global Gastrointestinal Market Size and Forecast by Region
        1.6.1 Global Gastrointestinal Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Gastrointestinal Market Size by Region, (2019-2030)
        1.6.3 North America Gastrointestinal Market Size and Prospect (2019-2030)
        1.6.4 Europe Gastrointestinal Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Gastrointestinal Market Size and Prospect (2019-2030)
        1.6.6 South America Gastrointestinal Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Gastrointestinal Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 AstraZenec
        2.1.1 AstraZenec Details
        2.1.2 AstraZenec Major Business
        2.1.3 AstraZenec Gastrointestinal Product and Solutions
        2.1.4 AstraZenec Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 AstraZenec Recent Developments and Future Plans
    2.2 Sanofi
        2.2.1 Sanofi Details
        2.2.2 Sanofi Major Business
        2.2.3 Sanofi Gastrointestinal Product and Solutions
        2.2.4 Sanofi Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Sanofi Recent Developments and Future Plans
    2.3 Bayer
        2.3.1 Bayer Details
        2.3.2 Bayer Major Business
        2.3.3 Bayer Gastrointestinal Product and Solutions
        2.3.4 Bayer Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Bayer Recent Developments and Future Plans
    2.4 Pfizer
        2.4.1 Pfizer Details
        2.4.2 Pfizer Major Business
        2.4.3 Pfizer Gastrointestinal Product and Solutions
        2.4.4 Pfizer Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Pfizer Recent Developments and Future Plans
    2.5 GlaxoSmithKline
        2.5.1 GlaxoSmithKline Details
        2.5.2 GlaxoSmithKline Major Business
        2.5.3 GlaxoSmithKline Gastrointestinal Product and Solutions
        2.5.4 GlaxoSmithKline Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 GlaxoSmithKline Recent Developments and Future Plans
    2.6 Teva
        2.6.1 Teva Details
        2.6.2 Teva Major Business
        2.6.3 Teva Gastrointestinal Product and Solutions
        2.6.4 Teva Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Teva Recent Developments and Future Plans
    2.7 Zeria（Tillotts）
        2.7.1 Zeria（Tillotts） Details
        2.7.2 Zeria（Tillotts） Major Business
        2.7.3 Zeria（Tillotts） Gastrointestinal Product and Solutions
        2.7.4 Zeria（Tillotts） Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Zeria（Tillotts） Recent Developments and Future Plans
    2.8 Perrigo
        2.8.1 Perrigo Details
        2.8.2 Perrigo Major Business
        2.8.3 Perrigo Gastrointestinal Product and Solutions
        2.8.4 Perrigo Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Perrigo Recent Developments and Future Plans
    2.9 Boehringer Ingelheim
        2.9.1 Boehringer Ingelheim Details
        2.9.2 Boehringer Ingelheim Major Business
        2.9.3 Boehringer Ingelheim Gastrointestinal Product and Solutions
        2.9.4 Boehringer Ingelheim Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Boehringer Ingelheim Recent Developments and Future Plans
    2.10 Purdue Pharma
        2.10.1 Purdue Pharma Details
        2.10.2 Purdue Pharma Major Business
        2.10.3 Purdue Pharma Gastrointestinal Product and Solutions
        2.10.4 Purdue Pharma Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Purdue Pharma Recent Developments and Future Plans
    2.11 C.B. Fleet
        2.11.1 C.B. Fleet Details
        2.11.2 C.B. Fleet Major Business
        2.11.3 C.B. Fleet Gastrointestinal Product and Solutions
        2.11.4 C.B. Fleet Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 C.B. Fleet Recent Developments and Future Plans
    2.12 Abbott
        2.12.1 Abbott Details
        2.12.2 Abbott Major Business
        2.12.3 Abbott Gastrointestinal Product and Solutions
        2.12.4 Abbott Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Abbott Recent Developments and Future Plans
    2.13 Jiangzhong
        2.13.1 Jiangzhong Details
        2.13.2 Jiangzhong Major Business
        2.13.3 Jiangzhong Gastrointestinal Product and Solutions
        2.13.4 Jiangzhong Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Jiangzhong Recent Developments and Future Plans
    2.14 Xian-Janssen
        2.14.1 Xian-Janssen Details
        2.14.2 Xian-Janssen Major Business
        2.14.3 Xian-Janssen Gastrointestinal Product and Solutions
        2.14.4 Xian-Janssen Gastrointestinal Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 Xian-Janssen Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Gastrointestinal Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Gastrointestinal by Company Revenue
        3.2.2 Top 3 Gastrointestinal Players Market Share in 2023
        3.2.3 Top 6 Gastrointestinal Players Market Share in 2023
    3.3 Gastrointestinal Market: Overall Company Footprint Analysis
        3.3.1 Gastrointestinal Market: Region Footprint
        3.3.2 Gastrointestinal Market: Company Product Type Footprint
        3.3.3 Gastrointestinal Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Gastrointestinal Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Gastrointestinal Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Gastrointestinal Consumption Value Market Share by Application (2019-2024)
    5.2 Global Gastrointestinal Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Gastrointestinal Consumption Value by Type (2019-2030)
    6.2 North America Gastrointestinal Consumption Value by Application (2019-2030)
    6.3 North America Gastrointestinal Market Size by Country
        6.3.1 North America Gastrointestinal Consumption Value by Country (2019-2030)
        6.3.2 United States Gastrointestinal Market Size and Forecast (2019-2030)
        6.3.3 Canada Gastrointestinal Market Size and Forecast (2019-2030)
        6.3.4 Mexico Gastrointestinal Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Gastrointestinal Consumption Value by Type (2019-2030)
    7.2 Europe Gastrointestinal Consumption Value by Application (2019-2030)
    7.3 Europe Gastrointestinal Market Size by Country
        7.3.1 Europe Gastrointestinal Consumption Value by Country (2019-2030)
        7.3.2 Germany Gastrointestinal Market Size and Forecast (2019-2030)
        7.3.3 France Gastrointestinal Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Gastrointestinal Market Size and Forecast (2019-2030)
        7.3.5 Russia Gastrointestinal Market Size and Forecast (2019-2030)
        7.3.6 Italy Gastrointestinal Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Gastrointestinal Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Gastrointestinal Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Gastrointestinal Market Size by Region
        8.3.1 Asia-Pacific Gastrointestinal Consumption Value by Region (2019-2030)
        8.3.2 China Gastrointestinal Market Size and Forecast (2019-2030)
        8.3.3 Japan Gastrointestinal Market Size and Forecast (2019-2030)
        8.3.4 South Korea Gastrointestinal Market Size and Forecast (2019-2030)
        8.3.5 India Gastrointestinal Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Gastrointestinal Market Size and Forecast (2019-2030)
        8.3.7 Australia Gastrointestinal Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Gastrointestinal Consumption Value by Type (2019-2030)
    9.2 South America Gastrointestinal Consumption Value by Application (2019-2030)
    9.3 South America Gastrointestinal Market Size by Country
        9.3.1 South America Gastrointestinal Consumption Value by Country (2019-2030)
        9.3.2 Brazil Gastrointestinal Market Size and Forecast (2019-2030)
        9.3.3 Argentina Gastrointestinal Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Gastrointestinal Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Gastrointestinal Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Gastrointestinal Market Size by Country
        10.3.1 Middle East & Africa Gastrointestinal Consumption Value by Country (2019-2030)
        10.3.2 Turkey Gastrointestinal Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Gastrointestinal Market Size and Forecast (2019-2030)
        10.3.4 UAE Gastrointestinal Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Gastrointestinal Market Drivers
    11.2 Gastrointestinal Market Restraints
    11.3 Gastrointestinal Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Gastrointestinal Industry Chain
    12.2 Gastrointestinal Upstream Analysis
    12.3 Gastrointestinal Midstream Analysis
    12.4 Gastrointestinal Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Gastrointestinal Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Gastrointestinal Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Gastrointestinal Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Gastrointestinal Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. AstraZenec Company Information, Head Office, and Major Competitors
    Table 6. AstraZenec Major Business
    Table 7. AstraZenec Gastrointestinal Product and Solutions
    Table 8. AstraZenec Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. AstraZenec Recent Developments and Future Plans
    Table 10. Sanofi Company Information, Head Office, and Major Competitors
    Table 11. Sanofi Major Business
    Table 12. Sanofi Gastrointestinal Product and Solutions
    Table 13. Sanofi Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Sanofi Recent Developments and Future Plans
    Table 15. Bayer Company Information, Head Office, and Major Competitors
    Table 16. Bayer Major Business
    Table 17. Bayer Gastrointestinal Product and Solutions
    Table 18. Bayer Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Bayer Recent Developments and Future Plans
    Table 20. Pfizer Company Information, Head Office, and Major Competitors
    Table 21. Pfizer Major Business
    Table 22. Pfizer Gastrointestinal Product and Solutions
    Table 23. Pfizer Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Pfizer Recent Developments and Future Plans
    Table 25. GlaxoSmithKline Company Information, Head Office, and Major Competitors
    Table 26. GlaxoSmithKline Major Business
    Table 27. GlaxoSmithKline Gastrointestinal Product and Solutions
    Table 28. GlaxoSmithKline Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. GlaxoSmithKline Recent Developments and Future Plans
    Table 30. Teva Company Information, Head Office, and Major Competitors
    Table 31. Teva Major Business
    Table 32. Teva Gastrointestinal Product and Solutions
    Table 33. Teva Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Teva Recent Developments and Future Plans
    Table 35. Zeria（Tillotts） Company Information, Head Office, and Major Competitors
    Table 36. Zeria（Tillotts） Major Business
    Table 37. Zeria（Tillotts） Gastrointestinal Product and Solutions
    Table 38. Zeria（Tillotts） Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Zeria（Tillotts） Recent Developments and Future Plans
    Table 40. Perrigo Company Information, Head Office, and Major Competitors
    Table 41. Perrigo Major Business
    Table 42. Perrigo Gastrointestinal Product and Solutions
    Table 43. Perrigo Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Perrigo Recent Developments and Future Plans
    Table 45. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
    Table 46. Boehringer Ingelheim Major Business
    Table 47. Boehringer Ingelheim Gastrointestinal Product and Solutions
    Table 48. Boehringer Ingelheim Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Boehringer Ingelheim Recent Developments and Future Plans
    Table 50. Purdue Pharma Company Information, Head Office, and Major Competitors
    Table 51. Purdue Pharma Major Business
    Table 52. Purdue Pharma Gastrointestinal Product and Solutions
    Table 53. Purdue Pharma Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Purdue Pharma Recent Developments and Future Plans
    Table 55. C.B. Fleet Company Information, Head Office, and Major Competitors
    Table 56. C.B. Fleet Major Business
    Table 57. C.B. Fleet Gastrointestinal Product and Solutions
    Table 58. C.B. Fleet Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 59. C.B. Fleet Recent Developments and Future Plans
    Table 60. Abbott Company Information, Head Office, and Major Competitors
    Table 61. Abbott Major Business
    Table 62. Abbott Gastrointestinal Product and Solutions
    Table 63. Abbott Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 64. Abbott Recent Developments and Future Plans
    Table 65. Jiangzhong Company Information, Head Office, and Major Competitors
    Table 66. Jiangzhong Major Business
    Table 67. Jiangzhong Gastrointestinal Product and Solutions
    Table 68. Jiangzhong Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 69. Jiangzhong Recent Developments and Future Plans
    Table 70. Xian-Janssen Company Information, Head Office, and Major Competitors
    Table 71. Xian-Janssen Major Business
    Table 72. Xian-Janssen Gastrointestinal Product and Solutions
    Table 73. Xian-Janssen Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 74. Xian-Janssen Recent Developments and Future Plans
    Table 75. Global Gastrointestinal Revenue (USD Million) by Players (2019-2024)
    Table 76. Global Gastrointestinal Revenue Share by Players (2019-2024)
    Table 77. Breakdown of Gastrointestinal by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 78. Market Position of Players in Gastrointestinal, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 79. Head Office of Key Gastrointestinal Players
    Table 80. Gastrointestinal Market: Company Product Type Footprint
    Table 81. Gastrointestinal Market: Company Product Application Footprint
    Table 82. Gastrointestinal New Market Entrants and Barriers to Market Entry
    Table 83. Gastrointestinal Mergers, Acquisition, Agreements, and Collaborations
    Table 84. Global Gastrointestinal Consumption Value (USD Million) by Type (2019-2024)
    Table 85. Global Gastrointestinal Consumption Value Share by Type (2019-2024)
    Table 86. Global Gastrointestinal Consumption Value Forecast by Type (2025-2030)
    Table 87. Global Gastrointestinal Consumption Value by Application (2019-2024)
    Table 88. Global Gastrointestinal Consumption Value Forecast by Application (2025-2030)
    Table 89. North America Gastrointestinal Consumption Value by Type (2019-2024) & (USD Million)
    Table 90. North America Gastrointestinal Consumption Value by Type (2025-2030) & (USD Million)
    Table 91. North America Gastrointestinal Consumption Value by Application (2019-2024) & (USD Million)
    Table 92. North America Gastrointestinal Consumption Value by Application (2025-2030) & (USD Million)
    Table 93. North America Gastrointestinal Consumption Value by Country (2019-2024) & (USD Million)
    Table 94. North America Gastrointestinal Consumption Value by Country (2025-2030) & (USD Million)
    Table 95. Europe Gastrointestinal Consumption Value by Type (2019-2024) & (USD Million)
    Table 96. Europe Gastrointestinal Consumption Value by Type (2025-2030) & (USD Million)
    Table 97. Europe Gastrointestinal Consumption Value by Application (2019-2024) & (USD Million)
    Table 98. Europe Gastrointestinal Consumption Value by Application (2025-2030) & (USD Million)
    Table 99. Europe Gastrointestinal Consumption Value by Country (2019-2024) & (USD Million)
    Table 100. Europe Gastrointestinal Consumption Value by Country (2025-2030) & (USD Million)
    Table 101. Asia-Pacific Gastrointestinal Consumption Value by Type (2019-2024) & (USD Million)
    Table 102. Asia-Pacific Gastrointestinal Consumption Value by Type (2025-2030) & (USD Million)
    Table 103. Asia-Pacific Gastrointestinal Consumption Value by Application (2019-2024) & (USD Million)
    Table 104. Asia-Pacific Gastrointestinal Consumption Value by Application (2025-2030) & (USD Million)
    Table 105. Asia-Pacific Gastrointestinal Consumption Value by Region (2019-2024) & (USD Million)
    Table 106. Asia-Pacific Gastrointestinal Consumption Value by Region (2025-2030) & (USD Million)
    Table 107. South America Gastrointestinal Consumption Value by Type (2019-2024) & (USD Million)
    Table 108. South America Gastrointestinal Consumption Value by Type (2025-2030) & (USD Million)
    Table 109. South America Gastrointestinal Consumption Value by Application (2019-2024) & (USD Million)
    Table 110. South America Gastrointestinal Consumption Value by Application (2025-2030) & (USD Million)
    Table 111. South America Gastrointestinal Consumption Value by Country (2019-2024) & (USD Million)
    Table 112. South America Gastrointestinal Consumption Value by Country (2025-2030) & (USD Million)
    Table 113. Middle East & Africa Gastrointestinal Consumption Value by Type (2019-2024) & (USD Million)
    Table 114. Middle East & Africa Gastrointestinal Consumption Value by Type (2025-2030) & (USD Million)
    Table 115. Middle East & Africa Gastrointestinal Consumption Value by Application (2019-2024) & (USD Million)
    Table 116. Middle East & Africa Gastrointestinal Consumption Value by Application (2025-2030) & (USD Million)
    Table 117. Middle East & Africa Gastrointestinal Consumption Value by Country (2019-2024) & (USD Million)
    Table 118. Middle East & Africa Gastrointestinal Consumption Value by Country (2025-2030) & (USD Million)
    Table 119. Gastrointestinal Raw Material
    Table 120. Key Suppliers of Gastrointestinal Raw Materials
List of Figures
    Figure 1. Gastrointestinal Picture
    Figure 2. Global Gastrointestinal Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Gastrointestinal Consumption Value Market Share by Type in 2023
    Figure 4. Prescription Gastrointestinal Drug
    Figure 5. OTC Gastrointestinal Drug
    Figure 6. Global Gastrointestinal Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 7. Gastrointestinal Consumption Value Market Share by Application in 2023
    Figure 8. Chronic Gastritis Picture
    Figure 9. Functional Dyspepsia Picture
    Figure 10. Peptic Ulcer Picture
    Figure 11. Acute Gastroenteritis Picture
    Figure 12. Others Picture
    Figure 13. Global Gastrointestinal Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 14. Global Gastrointestinal Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 15. Global Market Gastrointestinal Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 16. Global Gastrointestinal Consumption Value Market Share by Region (2019-2030)
    Figure 17. Global Gastrointestinal Consumption Value Market Share by Region in 2023
    Figure 18. North America Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 20. Asia-Pacific Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 21. South America Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 22. Middle East and Africa Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 23. Global Gastrointestinal Revenue Share by Players in 2023
    Figure 24. Gastrointestinal Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 25. Global Top 3 Players Gastrointestinal Market Share in 2023
    Figure 26. Global Top 6 Players Gastrointestinal Market Share in 2023
    Figure 27. Global Gastrointestinal Consumption Value Share by Type (2019-2024)
    Figure 28. Global Gastrointestinal Market Share Forecast by Type (2025-2030)
    Figure 29. Global Gastrointestinal Consumption Value Share by Application (2019-2024)
    Figure 30. Global Gastrointestinal Market Share Forecast by Application (2025-2030)
    Figure 31. North America Gastrointestinal Consumption Value Market Share by Type (2019-2030)
    Figure 32. North America Gastrointestinal Consumption Value Market Share by Application (2019-2030)
    Figure 33. North America Gastrointestinal Consumption Value Market Share by Country (2019-2030)
    Figure 34. United States Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 35. Canada Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 36. Mexico Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 37. Europe Gastrointestinal Consumption Value Market Share by Type (2019-2030)
    Figure 38. Europe Gastrointestinal Consumption Value Market Share by Application (2019-2030)
    Figure 39. Europe Gastrointestinal Consumption Value Market Share by Country (2019-2030)
    Figure 40. Germany Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 41. France Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 42. United Kingdom Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 43. Russia Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 44. Italy Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 45. Asia-Pacific Gastrointestinal Consumption Value Market Share by Type (2019-2030)
    Figure 46. Asia-Pacific Gastrointestinal Consumption Value Market Share by Application (2019-2030)
    Figure 47. Asia-Pacific Gastrointestinal Consumption Value Market Share by Region (2019-2030)
    Figure 48. China Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 49. Japan Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 50. South Korea Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 51. India Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 52. Southeast Asia Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 53. Australia Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 54. South America Gastrointestinal Consumption Value Market Share by Type (2019-2030)
    Figure 55. South America Gastrointestinal Consumption Value Market Share by Application (2019-2030)
    Figure 56. South America Gastrointestinal Consumption Value Market Share by Country (2019-2030)
    Figure 57. Brazil Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 58. Argentina Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 59. Middle East and Africa Gastrointestinal Consumption Value Market Share by Type (2019-2030)
    Figure 60. Middle East and Africa Gastrointestinal Consumption Value Market Share by Application (2019-2030)
    Figure 61. Middle East and Africa Gastrointestinal Consumption Value Market Share by Country (2019-2030)
    Figure 62. Turkey Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 63. Saudi Arabia Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 64. UAE Gastrointestinal Consumption Value (2019-2030) & (USD Million)
    Figure 65. Gastrointestinal Market Drivers
    Figure 66. Gastrointestinal Market Restraints
    Figure 67. Gastrointestinal Market Trends
    Figure 68. Porters Five Forces Analysis
    Figure 69. Manufacturing Cost Structure Analysis of Gastrointestinal in 2023
    Figure 70. Manufacturing Process Analysis of Gastrointestinal
    Figure 71. Gastrointestinal Industrial Chain
    Figure 72. Methodology
    Figure 73. Research Process and Data Source

Companies Mentioned

AstraZenec
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria（Tillotts）
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen